Adrenal function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Bochem, Andrea E ^a   Holleboom, Adriaan G ^a   Romijn, Johannes A ^a   Hoekstra, Menno ^b   Dallinga, Geesje M ^a   Motazacker, Mahdi M ^a   Hovingh, G Kees ^a   Kuivenhoven, Jan A ^c   Stroes, Erik S G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYCORTICOSTEROID; 17 OXOSTEROID; ABC TRANSPORTER A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TETRACOSACTIDE; ABCA1 PROTEIN, HUMAN;

ABCA1 GENE; ADRENAL FUNCTION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; LCAT GENE; MALE; STEROID URINE LEVEL; STEROIDOGENESIS; ADRENAL GLAND; GENETICS; METABOLISM; MIDDLE AGED; MUTATION;

17-KETOSTEROIDS; ADRENAL GLANDS; ADULT; ATP BINDING CASSETTE TRANSPORTER 1; CHOLESTEROL, HDL; FEMALE; HUMANS; MIDDLE AGED; MUTATION; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 84901361269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090967     Document Type: Article

References (39)

1. Borkowski A, Delcroix C, Levin S (1972) Metabolism of adrenal cholesterol in man. In vivo studies. J Clin Invest 51: 1664-1678.
2. Borkowski AJ, Levin S, Delcroix C, Mahler A, Verhas V (1967) Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. J Clin Invest 46: 797-811.
3. Hu J, Zhang Z, Shen WJ, Azhar S (2010) Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr Metab (Lond) 7: 47.: 47.
4. Illingworth DR, Lees AM, Lees RS (1983) Adrenal cortical function in homozygous familial hypercholesterolemia. Metabolism 32: 1045-1052. (Pubitemid 13022151)
5. Illingworth DR, Kenny TA, Orwoll ES (1982) Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 54: 27-33. (Pubitemid 13242129)
6. Illingworth DR, Kenny TA, Connor WE, Orwoll ES (1982) Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH. J Lab Clin Med 100: 115-126. (Pubitemid 12054904)
7. Illingworth DR, Orwoll ES, Connor WE (1980) Impaired cortisol secretion in abetalipoproteinemia. J Clin Endocrinol Metab 50: 977-979. (Pubitemid 10016463)
8. Illingworth DR, Alam NA, Lindsey S (1984) Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia. J Clin Endocrinol Metab 58: 206-211. (Pubitemid 14220540)
9. Yaguchi H, Tsutsumi K, Shimono K, Omura M, Sasano H et al. (1998) Involvement of high density lipoprotein as substrate cholesterol for steroidogenesis by bovine adrenal fasciculo-reticularis cells. Life Sci 62: 1387-1395. (Pubitemid 28143981)
10. Azhar S, Reaven E (2002) Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis. Mol Cell Endocrinol 195: 1-26. S0303720702002228 [pii].
11. Azhar S, Leers-Sucheta S, Reaven E (2003) Cholesterol uptake in adrenal and gonadal tissues: the SR-BI and 'selective' pathway connection. Front Biosci 8: s998-1029.
12. Reaven E, Chen YD, Spicher M, Azhar S (1984) Morphological evidence that high density lipoproteins are not internalized by steroid-producing cells during in situ organ perfusion. J Clin Invest 74: 1384-1397. 10.1172/JCI111549 [doi]. (Pubitemid 15206835)
13. Azhar S, Stewart D, Reaven E (1989) Utilization of cholesterol-rich lipoproteins by perfused rat adrenals. J Lipid Res 30: 1799-1810. (Pubitemid 20024859)
14. Hoekstra M, Meurs I, Koenders M, Out R, Hildebrand RB et al. (2008) Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting. J Lipid Res 49: 738-745. M700475-JLR200 [pii]; 10.1194/jlr.M700475-JLR200 [doi].
15. Hoekstra M, Ye D, Hildebrand RB, Zhao Y, Lammers B et al. (2009) Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J Lipid Res 50: 1039-1046.
16. van der Voort PH, Gerritsen RT, Bakker AJ, Boerma EC, Kuiper MA et al. (2003) HDL-cholesterol level and cortisol response to synacthen in critically ill patients. Intensive Care Med 29: 2199-2203. (Pubitemid 38030672)
17. Marik PE, Gayowski T, Starzl TE (2005) The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 33: 1254-1259. (Pubitemid 40827374)
18. Vergeer M, Korporaal SJ, Franssen R, Meurs I, Out R et al. (2011) Genetic variant of the scavenger receptor BI in humans. N Engl J Med 364: 136-145.
19. Bochem AE, Holleboom AG, Romijn JA, Hoekstra M, Dallinga GM et al. (2013) High-density lipoprotein as a source of cholesterol for adrenal steroidogenesis; a study in individuals with low plasma HDL-C. J Lipid Res. jlr.P033449 [pii]; 10.1194/jlr.P033449 [doi].
20. Duivenvoorden R, Holleboom AG, van den Bogaard B, Nederveen AJ, de Groot E et al. (2011) Cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging carriers of lecithin. J Am Coll Cardiol 58: 2481-2487. S0735-1097(11)03425-5 [pii]; 10.1016/j.jacc.2010.11.092 [doi].
21. Candini C, Schimmel AW, Peter J, Bochem AE, Holleboom AG et al. (2010) Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. Atherosclerosis 213: 492-498.
22. van Dam MJ, de Groot E, Clee SM, Hovingh GK, Roelants R et al. (2002) Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359: 37-42.
23. Holleboom AG, Kuivenhoven JA, Peelman F, Schimmel AW, Peter J et al. (2011) High prevalence of mutations in LCAT in patients with low high-density lipoprotein cholesterol levels in the netherlands identification and characterization of 8 new mutations in lcat. Hum Mutat 10.
24. van de Calseyde JF, Scholtis RJ, Schmidt NA, Leijten CJ (1972) Profiling urinary steroids. A reliable procedure. Clin Chim Acta 38: 103-111.
25. Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde JF et al. (1989) Steroid profile for urine: reference values. Clin Chem 35: 2281-2284. (Pubitemid 20017681)
26. Coolens JL, Van Baelen H, Heyns W (1987) Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 26: 197-202. (Pubitemid 17040122)
27. Doi SA, Lasheen I, Al-Humood K, Al-Shoumer KA (2006) Relationship between cortisol increment and basal cortisol: implications for the low-dose short adrenocorticotropic hormone stimulation test. Clin Chem 52: 746-749. clinchem.2005.061267 [pii]; 10.1373/clinchem.2005.061267 [doi].
28. Thaler LM, Blevins LS Jr (1998) The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 83: 2726-2729. (Pubitemid 28493767)
29. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM et al. (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113: 2363-2372. 113/19/2363 [pii]; 10.1161/CIRCULATIONAHA.106.174516 [doi].
30. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E et al. (1999) Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33: 1364-1368. (Pubitemid 29282655)
31. Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN et al. (2010) Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study. J Lipid Res 51: 416-421. P900038-JLR200 [pii]; 10.1194/P900038-JLR200 [doi].
32. Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM (1998) Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) 49: 287-292. (Pubitemid 28448936)
33. Puder JJ, Freda PU, Goland RS, Wardlaw SL (2001) Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J Clin Endocrinol Metab 86: 2403-2408. (Pubitemid 32545683)
34. Papadopoulos AD, Wardlaw SL (2000) Testosterone suppresses the response of the hypothalamic-pituitary-adrenal axis to interleukin-6. Neuroimmunomodulation 8: 39-44. 26451 [pii]; 26451 [doi].
35. Bethin KE, Vogt SK, Muglia LJ (2000) Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci U S A 97: 9317-9322. 97/16/9317 [pii].
36. Path G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA (1997) Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J Clin Endocrinol Metab 82: 2343-2349. (Pubitemid 27287610)
37. O'Connor MF, Motivala SJ, Valladares EM, Olmstead R, Irwin MR (2007) Sex differences in monocyte expression of IL-6: role of autonomic mechanisms. Am J Physiol Regul Integr Comp Physiol 293: R145-R151. 00752.2006 [pii]; 10.1152/ajpregu.00752.2006 [doi].
38. Silva C, Ines LS, Nour D, Straub RH, da Silva JA (2002) Differential male and female adrenal cortical steroid hormone and cortisol responses to interleukin-6 in humans. Ann N Y Acad Sci 966: 68-72. (Pubitemid 34729162)
39. Calabresi L, Baldassarre D, Castelnuovo S, Conca P, Bocchi L et al. (2009) Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120: 628-635. 120/7/628 [pii]; 10.1161/CIRCULATIONAHA.108.818143 [doi].